Bayer Aktie - Fundamentalanalyse - Dividendenrendite KGV

Bayer AG (ISIN: DE000BAY0017 , WKN: BAY001) Market price date: 22.06.2018 Market price: 98,840 EUR
Description Data
Symbol BAYN.DE
Market Capitalization 95.207.612.416,00 USD
Country Deutschland
Indices DaxEURO STOXX 50HDAX
Sector Pharma
Raw Data Source IFRS in Millionen EUR
Stock Split
Internet www.bayer.de
Last Balance Sheet Update 28.02.2018

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 22.06.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
14,17 10,05 2,83% 9,26 49,01 11,75 2,33 2,22

Firmenbeschreibung

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women\'s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.bayer.de